Event Topic:
Join Dr Jim Whittle (Medical Oncologist) and a panel of guest speakers including Dr Claire Phillips (Radiation Oncologist), Dr Sarah Cain (Neurosurgeon), and Dr Elizabeth Ahern (Medical Oncologist and immune-oncology researcher) to find out more about current treatment of low grade glioma, including clinical trials. The panel will answer questions submitted by participants, and other frequently asked questions they hear from their patients. This is recording of a Q&A webinar, held on 27th March 2024, with a mix of frequently asked questions based on the speakers’ experience, and questions submitted by the webinar participants.
About the speakers:
- Dr Jim Whittle, Medical Oncologist, Peter MacCallum Cancer Centre and Brain Cancer Research Lab Head, WEHI.
- Dr Claire Phillips, Radiation Oncologist, Deputy Director Radiation Oncology, Peter MacCallum Cancer Centre. Dr Phillips is a Deputy Director of Radiation Oncology at Peter MacCallum Cancer Centre Melbourne and a sub-specialist in Neuro-Oncology including Linac and Gamma Knife radiosurgery. Claire has lead clinical trials in brain and eye tumours, including the TROG* 08.02 (Short versus Long course RT for glioblastoma in the elderly) and TROG* 16.02 Local HERO study of radiosurgery and/ or neurosurgery alone for HER2+ breast cancer brain metastases. She is a current member of the Peter Mac Clinical Research Sponsorship Committee, the Brain Peri-Operative Programme Steering Committee and TROG* CNS Working Group. *TROG stands for Trans-Tasman Radiation Oncology Group
- Dr Sarah Cain, Neurosurgeon, Royal Melbourne Hospital. Dr Cain’s research focus is development and implementation of innovative research in the peri-operative setting to improve the survival outcomes for patients with brain cancer.
- Dr Elizabeth Ahern is a Medical Oncologist and stream lead of neuro-oncology at Monash Health where she also practices in early phase clinical trials, lung cancers, and skin cancers including melanoma. Dr. Ahern’s PhD research in neuro-oncology have yielded an international patent for a novel immunotherapeutic of which she is a co-owner. She is also an investigator on multiple research projects and clinical trials in the areas of neuro-oncology, lung cancer and melanomas and works with multi-disciplinary groups to improve outcomes of patients living with cancer.
Please note: these webinars are for education purposes only and should not be taken as individual medical advice. Consult with your healthcare team to find out what approach is best for you.
What time was the webinar held?
This webinar was held 12-1pm (Australian Eastern Daylight Time i.e. Melbourne/Sydney timezone) Wednesday 27th March 2024.